Trials / Completed
CompletedNCT01777620
A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | BOTOX® (onabotulinumtoxinA) injected into the areas of glabellar lines and crow's feet lines on Day 1. |
| DRUG | Normal Saline | Placebo (normal saline) injected into the areas of glabellar lines and crow's feet lines on Day 1. |
Timeline
- Start date
- 2013-01-31
- Primary completion
- 2013-05-29
- Completion
- 2013-07-31
- First posted
- 2013-01-29
- Last updated
- 2019-04-17
- Results posted
- 2014-05-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01777620. Inclusion in this directory is not an endorsement.